Applications of LC/MS in Qualitative Drug Metabolite Studies

Similar documents
Analysis of a Verapamil Microsomal Incubation using Metabolite ID and Mass Frontier TM

Application Note. Edgar Naegele. Abstract

Accelerating the Metabolite Identification Process Using High Resolution Q-TOF Data and Mass-MetaSite Software

A Rapid Approach to the Confirmation of Drug Metabolites in Preclinical and Clinical Bioanalysis Studies

Confirmation of In Vitro Nefazodone Metabolites using the Superior Fragmentation of the QTRAP 5500 LC/MS/MS System

Bioanalytical Chem: 4590: LC-MSMS of analgesics LC-MS Experiment Liquid Chromatography Mass Spectrometry (LC/MS)

Key Words Q Exactive, Accela, MetQuest, Mass Frontier, Drug Discovery

A Workflow Approach for the Identification and Structural Elucidation of Impurities of Quetiapine Hemifumarate Drug Substance

MassHunter TOF/QTOF Users Meeting

WADA Technical Document TD2003IDCR

Application Note. David A. Weil Zoltan Timar Michael Zumwalt Edgar Naegele. Abstract

An Effective Workflow for Impurity Analysis Incorporating High Quality HRAM LCMS & MSMS with Intelligent Automated Data Mining

Yun W. Alelyunas, Mark D. Wrona, Russell J. Mortishire-Smith, Nick Tomczyk, and Paul D. Rainville Waters Corporation, Milford, MA, USA INTRODUCTION

At-a-Glance. Verapamil C 27 H 38 N 2 O 4 M+H + =

Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS

Finnigan LCQ Advantage MAX

LC-MS Based Metabolomics

Stephen McDonald, Mark D. Wrona, Jeff Goshawk Waters Corporation, Milford, MA, USA INTRODUCTION

Thermo Finnigan LTQ. Specifications

Varian Galaxie Chromatography Data System for Preparative HPLC

Automatic Generation of Extract ion Chromatogram for Mass Spectral Peaks with Specific Isotope Labeled Patterns

Maximizing Triple Quadrupole Mass Spectrometry Productivity with the Agilent StreamSelect LC/MS System

All Ions MS/MS: Targeted Screening and Quantitation Using Agilent TOF and Q-TOF LC/MS Systems

Powerful Scan Modes of QTRAP System Technology

LC Technical Information

Identification and Characterization of an Isolated Impurity Fraction: Analysis of an Unknown Degradant Found in Quetiapine Fumarate

Computer-assisted analysis of complex natural product extracts

Metabolomics in an Identity Crisis? Am I a Feature or a Compound? The world leader in serving science

Application Note LCMS-112 A Fully Automated Two-Step Procedure for Quality Control of Synthetic Peptides

Agilent MassHunter Profinder: Solving the Challenge of Isotopologue Extraction for Qualitative Flux Analysis

LC walk-up system using the Agilent 1200 Series LC Method Development Solution and Agilent Easy Access software. Application Note

Technical Note. Introduction

Abstract. Experimental Sample Preparation

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

Mass Spectrometry. Hyphenated Techniques GC-MS LC-MS and MS-MS

Supporting Information. Labeled Ligand Displacement: Extending NMR-based Screening of Protein Targets

MassHunter METLIN Metabolite PCD/PCDL Quick Start Guide

Making Sense of Differences in LCMS Data: Integrated Tools

Quantitative Analysis of EtG and EtS in Urine Using FASt ETG and LC-MS/MS

MassHunter Software Overview

Live Webinar : How to be more Successful with your ACQUITY QDa Detector?

Application Note. Edgar Naegele. Abstract

Comprehensive Metabolite Profiling in a Discovery Environment, Coupled Workflows Enabled by HRMS

Rapid method development to study plasma stability of diverse pharmaceutical compounds using Rapid Resolution LC and triple quadrupole MS

Taking Full Advantage of UHPLC with Agilent 6460A Triple Quadrupole MS. Outline

Ultrafast Analysis of Buprenorphine and Norbuprenorphine in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System

EGASUS. 4D GCxGC TOFMS. Delivering the Right Results

Measurement of Metabolic Stability Using SIM and Identification of Metabolites by Data Dependent Full-Scan MS/MS and CNL Scanning

Translational Biomarker Core

Proudly serving laboratories worldwide since 1979 CALL for Refurbished & Certified Lab Equipment LCQ Deca XP Plus

Accurate Mass Measurements: Identifying Known Unknowns

A Q-TOF Generated, Metabolomics- Specifi c LC/MS/MS Library Facilitates Identifi cation of Metabolites in Malaria Infected Erythrocytes

MetWorks Metabolite Identification Software

Guide to Peptide Quantitation. Agilent clinical research

New Approaches in the Analysis of Amadori Compounds

High-sensitivity, high-throughput quantitation of catecholamine metabolites in urine by LC/MS/MS for clinical research

Analysis of Illegal Dyes in Food Matrices using Automated Online Sample Preparation with LC/MS

TANDEM MASS SPECTROSCOPY

NORBUPRENORPHINE (Buprenorphine s Metabolite ) BUPRENORPHINE in urine by GC/MS Code GC Method of Confirmation by GC-MS

VMA, HVA, 5-HIAA Urine LC-MS/MS Analysis Kit User Manual

Evaluation of a New HPLC, a New Tandem MS and a New Data Processing Software for General Clinical Use

Method Transfer between HPLC and UHPLC Instruments Equipment-related challenges and solutions

Pharmaceutical Impurity Identification and Profiling Using Agilent Q-TOF LC/MS Combined with Advanced MassHunter Data Processing Software

Thermo Scientific Pesticide Explorer Collection. Start-to-finish. workflows for pesticide analysis

Structural Analysis by In-Depth Impurity Search Using MetID Solution and High Accuracy MS/MS

Rapid Quan/Qual Metabolic Stability Analysis with Online Oxidative Metabolism Synthesis

C HA R AC T E RIZ AT IO N O F INK J E T P RINT E R C A RT RIDG E INK S USING A CHEMOMETRIC APPROACH

GAS CHROMATOGRAPHY MASS SPECTROMETRY. Pre-Lab Questions

Routine MS Detection for USP Chromatographic Methods

Application Note. Gas Chromatography/Mass Spectrometry/Food Safety. Abstract. Authors

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

Achieve confident synthesis control with the Thermo Scientific ISQ EC single quadrupole mass spectrometer

Analytical determination of testosterone in human serum using an Agilent Ultivo Triple Quadrupole LC/MS

ACD/AutoChrom Assisted Method Development for Challenging Separations. Vera Leshchinskaya February 7, 2018

Assay Robustness Improvement for Drug Urinalysis Using FAIMS and H-SRM on a Triple- Quadrupole Mass Spectrometer

SEAMLESS INTEGRATION OF MASS DETECTION INTO THE UV CHROMATOGRAPHIC WORKFLOW

Quan/Qual Analyses. Unmatched Confidence for. Thermo Scientific Q Exactive Orbitrap LC-MS/MS System. Identify Quantify Confirm

Determination of Beta-Blockers in Urine Using Supercritical Fluid Chromatography and Mass Spectrometry

Analysis of Polar Metabolites using Mass Spectrometry

[application note] ACQUITY UPLC/SQD ANALYSIS OF POLYMER ADDITIVES. Peter J. Lee, and Alice J. Di Gioia, Waters Corporation, Milford, MA, U.S.A.

Improved 6- Plex TMT Quantification Throughput Using a Linear Ion Trap HCD MS 3 Scan Jane M. Liu, 1,2 * Michael J. Sweredoski, 2 Sonja Hess 2 *

GC-APCI IMS of Diesel

Agilent G3212 GC-APCI Source

Hypericin Analysis by LC/MS

Quantitative Analysis of Water-Soluble B-Vitamins in Cereal Using Rapid Resolution LC/MS/MS. Application. Authors. Abstract.

New Dynamic MRM Mode Improves Data Quality and Triple Quad Quantification in Complex Analyses

Agilent MassHunter Quantitative Data Analysis

The Nanostream (Pasadena, CA) Veloce system,

5Cl-AKB48 and 5Br-AKB48

HPLC. GRATE Chromatography Lab Course. Dr. Johannes Ranke. September 2003

Traditional Herbal Medicine Structural Elucidation using SYNAPT HDMS

High-Resolution Sampling 2D-LC for Pharmaceutical Impurity Analysis

Detection of Trace Level Pharmaceuticals in Drinking Water by Online SPE Enrichment with the Agilent 1200 Infinity Series Online-SPE Solution

4000 Q TRAP LC/MS/MS System. Advanced Linear Ion Trap technology at the highest level of sensitivity 4000 QTRAP. LC/MS/MS System

Cerno Bioscience MassWorks: Acquiring Calibration Data on Agilent GC/MSDs

AppNote 2/2013. A High Throughput Automated Sample Preparation and Analysis Workfl ow for Comprehensive Toxicology Urine Screenings using LC/MS/MS

TOMAHAQ Method Construction

Choosing the metabolomics platform

Mass Spectrometry in MCAL

Quantitative Screening of 46 Illicit Drugs in Urine using Exactive Ultrahigh Resolution and Accurate Mass system

Transcription:

Applications of LC/M in Qualitative Drug Metabolite tudies

Case tudy: Identifying in vivo metabolites in human urine - sample cleanup and LC/M/M strategies Application detection of drug (Vanlev) metabolites in human urine limited sample need to identify major metabolites in high matrix background Approach on-line sample cleanup using small molecule trap column (maximize / ) Use instrument control language (ICL) on TQ to construct unique data-dependent acquisition modes using combined precursor, neutral loss, and product ion scan modes (maximize information per run)

Don t forget about sample cleanup!

Column witching ystem for Metabolite Cleanup ample Load Waste 2 Waters HPLC YMC-AQ C18 2.1x33mm 1 6 3 4 Gradient system 1 ml/min 5 HPLC Pump Wash solvent 0.1% TFA/H 2 Flow: 0.1 ml/min A Analytical Column YMC-AQ C18 4.6 x 150 mm Electrically Actuated Divert Valve Controlled by the Data ystem UV Finnigan TQ 700

LC/UV and Full-can LC/M Chromatograms of BM-186716 and its Metabolites in Human Urine Without Prior ample Clean-up 100 80 UV 220 nm 9.991 e+0 60 40 ormalized Intensity 20 0 100 80 RIC Full-can M 200-800 amu 1.345 e+07 60 40 20 0 8:20 16:40 25:00 33:20 Time (minutes)

LC/UV and Full-can LC/M Chromatograms of BM-186716 and its Metabolites in Human Urine Using an n-line Clean-up Column 100 80 60 UV 220 nm 9.991 e+0 ormalized Intensity 40 20 0 100 80 60 40 RIC Full-can M 200-800 amu 2.801 e+07 20 0 8:20 16:40 25:00 33:20 Time (minutes)

Extracted Ions of Metabolites of BM-186716 in Human Urine from Full-can LC/M Chromatograms: Before Use of Clean-up Column m/z= 423 6.693 e+04 m/z= 528 2.637 e+05 m/z= 585 1.272 e+04 m/z= 599 5.981 e+04 m/z= 615 3.856 e+04 m/z= 704 5.451 e+04 8:20 16:40 25:00 33:20 Time (minute s )

Extracted Ions of Metabolites of BM-186716 in Human Urine from Full- can LC/M Chromatograms: After Use of Clean-up Column m/z= 423 2.282 e+05 m/z= 528 6.401 e+05 m/z= 585 3.669 e+05 m/z= 599 1.958 e+05 m/z= 615 1.073 e+05 m/z= 704 1.867 e+05 8:20 16:40 25:00 33:20 Time (minutes )

Effect of Clean-up Column on bserved Molecular Ion pecies (Rt ~ 20min) Direct Injection on Analytical Column M+a + 621.1 M+H + M+K + 599.1 637.0 H 3 C H 6 H 8 C 6 2C Glucuronide Injection on Clean-up Column M+H + 599.1 M+a + 621.1 M+K + 637.0 500 550 600 650 700 m/z

Metabolite LC/M profiling in complex mixtures Traditional Approach Run LC/M and catalog potential metabolites (+16, +32, etc ). et up additional runs to collect product ion M/M data on all of these signals r, possibly collect both M and product ion M/M in a data-dependent mode in a single run Watch out: data-dependent product scans can be problematic in vivo metabolite samples due to endogenous material. A peak at every mass can lead to collection many useless product ion spectra which are not drug-related. Can perform precursor and neutral loss scans to search for relevant metabolites, but collection of data and sorting through signals is very labor intensive and time-consuming. If these are in vivo metabolites, you may run out of sample first!

Metabolite LC/M profiling in complex mixtures General precursor and neutral loss scanning approach for metabolite screening Carefully study fragmentation of parent drug Look for characteristic neutral losses or characteristic fragment ions in the product ion spectrum Use characteristic fragment ions to set up precursor scans Use characteristic neutral losses to set up neutral loss scans Add other neutral loss scans (e.g., L of 176 for glucuronidation) Run these LC/M/M experiments Perform product ion scans on any new potential metabolites with new LC/M/M experiments Can iterate through this approach as new metabolites are discovered Even more efficient! Use the precursor and neutral loss scans to trigger product ion scans Collect only potentially drug-related product ion scans Get more done with less sample in less time

Parent Ion/eutral Loss election H H 128 H 2 C BM-186716, DMPI eutral Loss of 176 gives glucuronide conjugates Parents of 128, other metabolites

Data-Dependent M/M Using Pre-Cursor Ion and eutral Loss canning to Detect Drug Metabolites LC/M/M Chromatogram 1 3 2 4 5 cans 1-2: Detect peak in neutral loss or pre-cursor ion scan mode cans 3-5: Collect product-ion scans Pre-set Threshold Time The TQ is scanned in either the neutral loss or pre-cursor ion scan modes The ICL procedure requires that the ion intensity of a detected mass surpass a pre-set threshold for two consecutive scans. When this condition is met, three product ion spectra for that mass are acquired.

BM-186716 and elected Metabolites (M+H) + = 585 H H 6 H 8 C 6 Glucuronide 2 C H 3 C H H 2 C (M+H) + = 423 CH 3 H 6 H 8 C 6 Glucuronide (M+H) + = 615 2 C H H H 2 C BM-186716 (M+H) + = 409 H 3 C H 6 H 8 C 6 Glucuronide 2 C (M+H) + = 599 H H 2 C H 2 H H H 2 C H 2 H H 2 C 6 H 8 C 6 Glucuronide 2 C (M+H) + = 528 (M+H) + = 704

Metabolite ID software can be used to assist with metabolite characterization

Metabolite ID input expected drug modifications

Metabolite ID Metabolite Data Browser - Extracted Modifications parent +16 +32 M M/M

Metabolite ID Metabolite Data Browser - M/M Correlation * *

High-Throughput LC/M Metabolic tability

High Throughput Metabolic tability Analyze many (thousands) of drug candidates to evaluate and rank compounds on the basis of metabolic stability Perform in vitro incubations w/ and wo/activator Use a fast LC/M system and method (1.5 min/sample) Export integrated peaks areas to spreadsheet and/or data base Ratio the signals from activated vs. non-activated in vitro metabolite incubations Visualize data using color coded sample status

High Throughput LC/UV/ELD/M Metabolic ystem tability ystem Pre-clinical Predictive Indicators Ion Trap M (Finnigan LCQ Duo) MAGIC 2002 Integrated HPLC, Finnigan LCQ Duo, Alcott A, integrated via Finnigan / custom software Integrated HPLC (MAGIC 2002) Autosampler (Alcott A) Flow: 1.5 mls/min Column: YMC D-AQ, 2X20mm, 5u M: Data directed, F and M/M UV: 200 and 220 nm, VWD 1.1 min method, 1.4 min full cycle, 750 samples/18 hr 0.05 min wide peaks 18-23 fully resolved peaks possible! Low flow rate, low delay volume, low psi nly slight decrease in theoretical peaks imilar cost to single quadrupole system Custom programming interface

Metabolic tability Buspirone - Human Liver Microsomes - Extracted Ions Parent Parent Internal tandard Internal tandard Activated - A on-activated -

Plate Level creening View ADME/TX - creen ummary - Metabolic tability Calculation PA - Parent-Activated P - Parent-on-Activated A - tandard-activated - tandard-on-activated 1 - (PA/A) (P/) Green = K Yellow =? Red = Bad

Conclusions In vivo metabolite samples still pose significant challenges for LC/M/M elucidation imple sample cleanup steps can result in dramatic improvement Intelligent data-dependent scanning can help to efficiently locate metabolites in the presence of matrix background High-throughput LC/M can be used to rank metabolic stability of compounds ew software tools (e.g., Metabolite ID) are useful in speeding the identification and characterization of drug metabolites

Acknowledgments Mark anders, Mike edved, Rich Gedamke (BM) Jeff Whitney (ovatia)